NEW YORK, Sept. 14, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that the successful commercial launch of…Read More
You might also be interested in reading Diana Biggs Joins the Board of Directors of HIVE Blockchain Switzerland AG.
